The data originate from a combination of field-based sources – from mapCrowders – and scientific publications. mapCrowd prioritizes data from mapCrowders, when available, then data from scientific publications.
mapCrowd relies on a network of national HCV experts and advocates, or “mapCrowders,” who act as focal points for data collection. Most mapCrowders are affiliated with non-governmental organizations (NGOs). They are selected for their expertise in HCV advocacy and their capacity to obtain country-level information from a variety of sources.
Since mapCrowd was launched in February 2016, HCV experts and advocates are provided technical assistance and granted access to their respective country profile, upon review of their background and ability to gather relevant data. mapCrowders are then able to update online data on HCV at the national level according to their research and network. In some cases, respondents report that data is hard to obtain or only partially available (such as data on yearly national treatment uptake). Where possible, mapCrowders work with Ministries of Health to obtain the most up-to-date information and complete missing data.
As for January 2019, 46 countries have been fully or partially filled in by mapCrowders:
Algeria, Argentina, Australia, Belarus, Belgium, Brazil, Bulgaria, Cambodia, Cameroon, Canada, China, Cote d'Ivoire, Czech Republic, Egypt, France, Georgia, Germany, Greece, Guinea, Hungary, India, Indonesia, Iran, Ireland, Italy, Kazakhstan, Kenya, Lebanon, Malaysia, Morocco, Myanmar, Pakistan, Poland, Portugal, Romania, Russia, Spain, Switzerland, Slovak Republic, Tanzania, Thailand, Tunisia, Ukraine, United Kingdom, United States and Vietnam.
To supplement their contributions, mapCrowd also incorporates data gathered from a literature review
of peer-reviewed medical journals, expert reports, and institutional research that are listed per topic below.